Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced jaundice.

J Neuberger

    Bailliere'S Clinical Gastroenterology
    |April 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Many drugs can cause drug-associated cholestasis, a condition impairing bile flow. While often resolving within months, diagnosis relies on symptoms, biochemistry, and excluding other causes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The effect on consent rates for deceased organ donation in Wales after the introduction of an opt-out system.

    Anaesthesia·2020
    Same author

    Editorial: covert hepatic encephalopathy-silent but serious.

    Alimentary pharmacology & therapeutics·2018
    Same author

    Confirmation of specificity of reactivity in a solid phase ELISA for the detection of hepatitis E viral antigen improves utility of the assay.

    Journal of virological methods·2017
    Same author

    Donors With Immune Thrombocytopenia: Do They Pose a Risk to Transplant Recipients?

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same author

    The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis.

    Alimentary pharmacology & therapeutics·2016
    Same author

    2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same journal

    Index.

    Bailliere's clinical gastroenterology·2020
    Same journal

    Home enteral and parenteral nutrition in children.

    Bailliere's clinical gastroenterology·1999
    Same journal

    Nutritional support in malnourished paediatric patients.

    Bailliere's clinical gastroenterology·1999
    Same journal

    Cholestasis and end-stage liver disease.

    Bailliere's clinical gastroenterology·1999
    Same journal

    Cystic fibrosis: nutritional consequences and management.

    Bailliere's clinical gastroenterology·1999
    Same journal

    Pancreatic diseases (excluding cystic fibrosis).

    Bailliere's clinical gastroenterology·1999
    See all related articles

    Area of Science:

    • Hepatology
    • Clinical Pharmacology

    Background:

    • Drug-associated cholestasis is a significant clinical issue.
    • It presents with symptoms similar to other forms of cholestasis, including jaundice, pale stools, and dark urine.

    Purpose of the Study:

    • To review the clinical presentation, biochemical features, and diagnostic approaches to drug-associated cholestasis.
    • To discuss the potential mechanisms and prognosis of drug-induced bile flow impairment.

    Main Methods:

    • Literature review of drug-associated cholestasis.
    • Analysis of clinical and biochemical presentations.
    • Discussion of diagnostic criteria and differential diagnoses.

    Main Results:

    • Drug-associated cholestasis shares symptoms with other cholestatic conditions; eosinophilia may indicate drug involvement.

    Related Experiment Videos

  • Most cases resolve within 3 months, though jaundice may persist longer.
  • Progression to cirrhosis is rare, but some patients may develop a primary biliary cirrhosis-like syndrome.

    • Conclusions:

    • Diagnosis is typically based on temporal association with drug exposure and exclusion of other causes.
    • Mechanisms involve altered bile formation or excretion.
    • While generally benign, long-term monitoring may be necessary for some patients.